AGEN
Agenus Inc
Price:  
3.69 
USD
Volume:  
303,754.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Agenus EV/EBITDA

-1538.5%
Upside

As of 2026-03-24, the EV/EBITDA ratio of Agenus Inc (AGEN) is -6.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Agenus's latest enterprise value is 426.11 mil USD. Agenus's TTM EBITDA according to its financial statements is -70.08 mil USD. Dividing these 2 quantities gives us the above Agenus EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.0x - 15.6x 13.8x
Forward P/E multiples 14.5x - 20.8x 18.0x
Fair Price (49.57) - (52.36) (53.08)
Upside -1443.3% - -1518.9% -1538.5%
3.69 USD
Stock Price
(53.08) USD
Fair Price

Agenus EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-17 -6.20
2026-03-16 -5.93
2026-03-13 -5.85
2026-03-12 -5.81
2026-03-11 -5.93
2026-03-10 -5.96
2026-03-09 -5.87
2026-03-06 -5.80
2026-03-05 -5.78
2026-03-04 -5.89
2026-03-03 -5.88
2026-03-02 -5.95
2026-02-27 -5.94
2026-02-26 -5.95
2026-02-25 -5.90
2026-02-24 -5.90
2026-02-23 -5.84
2026-02-20 -5.84
2026-02-19 -5.89
2026-02-18 -5.84
2026-02-17 -5.83
2026-02-13 -5.78
2026-02-12 -5.76
2026-02-11 -5.81
2026-02-10 -5.84
2026-02-09 -5.81
2026-02-06 -5.79
2026-02-05 -5.72
2026-02-04 -5.77
2026-02-03 -5.77
2026-02-02 -5.76
2026-01-30 -5.75
2026-01-29 -5.81
2026-01-28 -5.86
2026-01-27 -5.89
2026-01-26 -5.82
2026-01-23 -5.91
2026-01-22 -5.96
2026-01-21 -5.97
2026-01-20 -5.96
2026-01-16 -5.95
2026-01-15 -6.08
2026-01-14 -6.46
2026-01-13 -6.44
2026-01-12 -6.30
2026-01-09 -6.17
2026-01-08 -6.10
2026-01-07 -6.08
2026-01-06 -6.00
2026-01-05 -5.90